Icon
+91 94997 68112
Login Register

VOGELXO - (12.5MG/1250MG)

TESTOSTERONE None
12.5MG/1250MG
Less Than $1000 mn
None None
None None
None None
Vogelxo is an androgen indicated for testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: • Primary hypogonadism (congenital or acquired). • Hypogonadotropic hypogonadism (congenital or acquired).
Yes
VOGELXO Patent 1 Patent 2 Patent 3 Patent 4
*** *********

VOGELXO - (50MG/5000MG)

TESTOSTERONE None
50MG/5000MG
Less Than $1000 mn
None None
None None
None None
Vogelxo is an androgen indicated for testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: • Primary hypogonadism (congenital or acquired). • Hypogonadotropic hypogonadism (congenital or acquired).
Yes
VOGELXO Patent 1 Patent 2 Patent 3 Patent 4
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.